These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2147707)

  • 1. Severe hepatotoxic reaction with progression to cirrhosis after use of a novel retinoid (acitretin).
    van Ditzhuijsen TJ; van Haelst UJ; van Dooren-Greebe RJ; van de Kerkhof PC; Yap SH
    J Hepatol; 1990 Sep; 11(2):185-8. PubMed ID: 2147707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent etretinate levels in plasma after changing the therapy to acitretin.
    Lambert WE; De Leenheer AP; De Bersaques JP; Kint A
    Arch Dermatol Res; 1990; 282(5):343-4. PubMed ID: 2145814
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacokinetics of etretinate, acitretin and 13-cis-acitretin: new results and advantages of blood level oriented clinical use].
    Gollnick H; Rinck G; Bitterling T; Orfanos CE
    Z Hautkr; 1990 Jan; 65(1):40-50. PubMed ID: 2139274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acitretin therapy in keratinization disorders].
    van Dooren-Greebe RJ; van de Kerkhof PC; Steijlen PM; Happle R
    Ned Tijdschr Geneeskd; 1990 Oct; 134(41):1995-2000. PubMed ID: 2146515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acitretin and etretinate in the treatment of palmoplantar pustulosis: a double-blind comparative trial.
    Lassus A; Geiger JM
    Br J Dermatol; 1988 Dec; 119(6):755-9. PubMed ID: 2974306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of etretinate in psoriatic patients with liver fibrosis.
    Larsen FG; Nielsen-Kudsk F; Jakobsen P; Kragballe K
    Pharmacol Toxicol; 1989 Nov; 65(5):393-7. PubMed ID: 2533684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acitretin in the symptomatic therapy for severe recessive x-linked ichthyosis.
    Bruckner-Tuderman L; Sigg C; Geiger JM; Gilardi S
    Arch Dermatol; 1988 Apr; 124(4):529-32. PubMed ID: 2965549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acitretin (Ro 10-1670) in the treatment of severe psoriasis. A randomized double-blind parallel study comparing acitretin and etretinate.
    Ledo A; Martín M; Geiger JM; Marrón JM
    Int J Dermatol; 1988 Nov; 27(9):656-60. PubMed ID: 2976406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum lipid changes during acitretin (etretin) treatment of psoriasis and palmo-plantar pustulosis.
    Vahlquist C; Selinus I; Vessby B
    Acta Derm Venereol; 1988; 68(4):300-5. PubMed ID: 2459874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acitretin in the treatment of severe psoriasis: a randomized double-blind study comparing acitretin and etretinate.
    Meffert H; Sönnichsen N
    Acta Derm Venereol Suppl (Stockh); 1989; 146():176-7. PubMed ID: 2532846
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro interactions of the aromatic retinoids Ro 10-9359 (etretinate) and Ro 10-1670 (acitretin), its main metabolite, with human serum lipoproteins and albumin.
    Carillet V; Morlière P; Mazière JC; Hüppe G; Santus R; Dubertret L
    Biochim Biophys Acta; 1990 Nov; 1055(2):98-101. PubMed ID: 2146977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acitretin versus etretinate in severe psoriasis. A double-blind randomized Nordic multicenter study in 168 patients.
    Bjerke JR; Geiger JM
    Acta Derm Venereol Suppl (Stockh); 1989; 146():206-7. PubMed ID: 2532847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoid concentrations in skin, serum and adipose tissue of patients treated with etretinate.
    Rollman O; Vahlquist A
    Br J Dermatol; 1983 Oct; 109(4):439-47. PubMed ID: 6226308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind comparison of acitretin and etretinate in the treatment of severe psoriasis. Results of a Nordic multicentre study.
    Kragballe K; Jansén CT; Geiger JM; Bjerke JR; Falk ES; Gip L; Hjorth N; Lauharanta J; Mork NJ; Reunala T
    Acta Derm Venereol; 1989; 69(1):35-40. PubMed ID: 2563606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind comparison of acitretin and etretinate in combination with bath PUVA in the treatment of extensive psoriasis.
    Lauharanta J; Geiger JM
    Br J Dermatol; 1989 Jul; 121(1):107-12. PubMed ID: 2527054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic retinoid therapy for psoriasis.
    Lowe NJ; Lazarus V; Matt L
    J Am Acad Dermatol; 1988 Jul; 19(1 Pt 2):186-91. PubMed ID: 2970476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective study of skeletal changes during short-term acitretin therapy.
    Hohl D; Pelloni F; Sigg C; Gilardi S; Jung T
    Dermatology; 1992; 185(1):23-6. PubMed ID: 1386262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acitretin. A review of its pharmacology and therapeutic use.
    Pilkington T; Brogden RN
    Drugs; 1992 Apr; 43(4):597-627. PubMed ID: 1377120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acitretin (Neotigason). A review of pharmacokinetics and teratogenicity and hypothesis on metabolic pathways.
    Bouvy ML; Sturkenboom MC; Cornel MC; De Jong-Van den Berg LT; Stricker BH; Wesseling H
    Pharm Weekbl Sci; 1992 Apr; 14(2):33-7. PubMed ID: 1388261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Etretinate: pro and con. Risk-benefit analysis of systemic retinoid therapy in psoriasis and recent developments: free aromatic acid, arotinoids].
    Gollnick H; Orfanos CE
    Hautarzt; 1985 Jan; 36(1):2-9. PubMed ID: 3156105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.